Literature DB >> 10739764

Different mutations in the LMNA gene cause autosomal dominant and autosomal recessive Emery-Dreifuss muscular dystrophy.

M Raffaele Di Barletta1, E Ricci, G Galluzzi, P Tonali, M Mora, L Morandi, A Romorini, T Voit, K H Orstavik, L Merlini, C Trevisan, V Biancalana, I Housmanowa-Petrusewicz, S Bione, R Ricotti, K Schwartz, G Bonne, D Toniolo.   

Abstract

Emery-Dreifuss muscular dystrophy (EMD) is a condition characterized by the clinical triad of early-onset contractures, progressive weakness in humeroperoneal muscles, and cardiomyopathy with conduction block. The disease was described for the first time as an X-linked muscular dystrophy, but autosomal dominant and autosomal recessive forms were reported. The genes for X-linked EMD and autosomal dominant EMD (AD-EMD) were identified. We report here that heterozygote mutations in LMNA, the gene for AD-EMD, may cause diverse phenotypes ranging from typical EMD to no phenotypic effect. Our results show that LMNA mutations are also responsible for the recessive form of the disease. Our results give further support to the notion that different genetic forms of EMD have a common pathophysiological background. The distribution of the mutations in AD-EMD patients (in the tail and in the 2A rod domain) suggests that unique interactions between lamin A/C and other nuclear components exist that have an important role in cardiac and skeletal muscle function.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10739764      PMCID: PMC1288205          DOI: 10.1086/302869

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  30 in total

1.  Nuclear lamin A/C R482Q mutation in canadian kindreds with Dunnigan-type familial partial lipodystrophy.

Authors:  H Cao; R A Hegele
Journal:  Hum Mol Genet       Date:  2000-01-01       Impact factor: 6.150

Review 2.  Heart to heart: from nuclear proteins to Emery-Dreifuss muscular dystrophy.

Authors:  G E Morris; S Manilal
Journal:  Hum Mol Genet       Date:  1999       Impact factor: 6.150

3.  Emery-Dreifuss muscular dystrophy: disease spectrum and differential diagnosis.

Authors:  T Voit; O Krogmann; H G Lenard; E Neuen-Jacob; W Wechsler; H H Goebel; G Rahlf; A Lindinger; C Nienaber
Journal:  Neuropediatrics       Date:  1988-05       Impact factor: 1.947

4.  An autosomal-dominant dystrophy with humeropelvic distribution and cardiomyopathy.

Authors:  G M Fenichel; Y C Sul; A W Kilroy; R Blouin
Journal:  Neurology       Date:  1982-12       Impact factor: 9.910

5.  Emery-Dreifuss muscular dystrophy with autosomal dominant transmission.

Authors:  R G Miller; R B Layzer; M A Mellenthin; M Golabi; R A Francoz; J C Mall
Journal:  Neurology       Date:  1985-08       Impact factor: 9.910

6.  Unusual type of benign x-linked muscular dystrophy.

Authors:  A E Emery; F E Dreifuss
Journal:  J Neurol Neurosurg Psychiatry       Date:  1966-08       Impact factor: 10.154

7.  A genetic variant of Emery-Dreifuss disease. Muscular dystrophy with humeropelvic distribution, early joint contracture, and permanent atrial paralysis.

Authors:  K Takamoto; K Hirose; M Uono; I Nonaka
Journal:  Arch Neurol       Date:  1984-12

Review 8.  Muscular dystrophies: alterations in a limited number of cellular pathways?

Authors:  D Toniolo; C Minetti
Journal:  Curr Opin Genet Dev       Date:  1999-06       Impact factor: 5.578

9.  Lamin A/C gene mutation associated with dilated cardiomyopathy with variable skeletal muscle involvement.

Authors:  G L Brodsky; F Muntoni; S Miocic; G Sinagra; C Sewry; L Mestroni
Journal:  Circulation       Date:  2000-02-08       Impact factor: 29.690

10.  Loss of A-type lamin expression compromises nuclear envelope integrity leading to muscular dystrophy.

Authors:  T Sullivan; D Escalante-Alcalde; H Bhatt; M Anver; N Bhat; K Nagashima; C L Stewart; B Burke
Journal:  J Cell Biol       Date:  1999-11-29       Impact factor: 10.539

View more
  89 in total

Review 1.  Lipoatrophic diabetes and other related syndromes.

Authors:  Elif Arioglu Oral
Journal:  Rev Endocr Metab Disord       Date:  2003-03       Impact factor: 6.514

2.  Emery-Dreifuss muscular dystrophy in the evaluation of decreased spinal mobility and joint contractures.

Authors:  Kamil Goncu; Rengin Guzel; Fusun Guler-Uysal
Journal:  Clin Rheumatol       Date:  2003-10-21       Impact factor: 2.980

Review 3.  Evolving molecular diagnostics for familial cardiomyopathies: at the heart of it all.

Authors:  Thomas E Callis; Brian C Jensen; Karen E Weck; Monte S Willis
Journal:  Expert Rev Mol Diagn       Date:  2010-04       Impact factor: 5.225

Review 4.  Inner nuclear membrane proteins: impact on human disease.

Authors:  Iván Méndez-López; Howard J Worman
Journal:  Chromosoma       Date:  2012-02-04       Impact factor: 4.316

Review 5.  Emery-Dreifuss muscular dystrophy.

Authors:  Antoine Muchir; Howard J Worman
Journal:  Curr Neurol Neurosci Rep       Date:  2007-01       Impact factor: 5.081

Review 6.  Laminopathies: multiple disorders arising from defects in nuclear architecture.

Authors:  Veena K Parnaik; Kaliyaperumal Manju
Journal:  J Biosci       Date:  2006-09       Impact factor: 1.826

Review 7.  Nuclear mechanics in disease.

Authors:  Monika Zwerger; Chin Yee Ho; Jan Lammerding
Journal:  Annu Rev Biomed Eng       Date:  2011-08-15       Impact factor: 9.590

Review 8.  Adult stem cell maintenance and tissue regeneration in the ageing context: the role for A-type lamins as intrinsic modulators of ageing in adult stem cells and their niches.

Authors:  Vanja Pekovic; Christopher J Hutchison
Journal:  J Anat       Date:  2008-07       Impact factor: 2.610

9.  Lamin A N-terminal phosphorylation is associated with myoblast activation: impairment in Emery-Dreifuss muscular dystrophy.

Authors:  V Cenni; P Sabatelli; E Mattioli; S Marmiroli; C Capanni; A Ognibene; S Squarzoni; N M Maraldi; G Bonne; M Columbaro; L Merlini; G Lattanzi
Journal:  J Med Genet       Date:  2005-03       Impact factor: 6.318

10.  Autosomal recessive forms of Charcot-Marie-Tooth disease.

Authors:  J M Vallat; D Grid; C Magdelaine; F Sturtz; M Tazir
Journal:  Curr Neurol Neurosci Rep       Date:  2004-09       Impact factor: 5.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.